PURLs: consider this option for heavy menstrual bleeding. 2011

Robert Levy, and Shailendra Prasad, and Kate Rowland
North Memorial Family Medicine Residency, University of Minnesota, Minneapolis, USA.

Women who fail to respond to--or are unable to tolerate--other treatments for heavy menstrual blood loss now have another choice.

UI MeSH Term Description Entries
D008595 Menorrhagia Excessive uterine bleeding during MENSTRUATION. Hypermenorrhea,Heavy Menstrual Bleeding,Heavy Periods,Heavy Period,Menstrual Bleeding, Heavy
D008598 Menstruation The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000933 Antifibrinolytic Agents Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders. Antifibrinolysin,Antifibrinolysins,Antifibrinolytic,Antifibrinolytic Agent,Antiplasmin,Antiplasmins,Antifibrinolytics,Plasmin Inhibitor,Plasmin Inhibitors,Agent, Antifibrinolytic,Agents, Antifibrinolytic,Inhibitor, Plasmin,Inhibitors, Plasmin
D014148 Tranexamic Acid Antifibrinolytic hemostatic used in severe hemorrhage. AMCHA,AMCA,Amchafibrin,Anvitoff,Cyklokapron,Exacyl,KABI 2161,Spotof,Transamin,Ugurol,t-AMCHA,trans-4-(Aminomethyl)cyclohexanecarboxylic Acid

Related Publications

Robert Levy, and Shailendra Prasad, and Kate Rowland
January 2012, Nursing for women's health,
Robert Levy, and Shailendra Prasad, and Kate Rowland
March 2011, Women's health (London, England),
Robert Levy, and Shailendra Prasad, and Kate Rowland
January 2007, BMJ (Clinical research ed.),
Robert Levy, and Shailendra Prasad, and Kate Rowland
January 2017, The Journal of family practice,
Robert Levy, and Shailendra Prasad, and Kate Rowland
April 2016, The Journal of family practice,
Robert Levy, and Shailendra Prasad, and Kate Rowland
January 2013, Advance for NPs & PAs,
Robert Levy, and Shailendra Prasad, and Kate Rowland
October 2016, Nursing standard (Royal College of Nursing (Great Britain) : 1987),
Robert Levy, and Shailendra Prasad, and Kate Rowland
January 2016, Women's health (London, England),
Robert Levy, and Shailendra Prasad, and Kate Rowland
September 2014, Women's health (London, England),
Robert Levy, and Shailendra Prasad, and Kate Rowland
April 2018, The Cochrane database of systematic reviews,
Copied contents to your clipboard!